BHVN (Biohaven Ltd.) Stock Financials & Earnings | Market Cap Arena

BHVN (Biohaven Ltd.) Stock Financials & Earnings | Market Cap Arena

BHVNBiohaven Ltd.

Mkt Cap$1B

Healthcare·Biotechnology·🇺🇸 United States·NYSE

Revenue (TTM)$0

Net Income (TTM)-$739M

EPS (TTM)-$6.96

Free Cash Flow (TTM)-$610M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$78M
Q2 23	$0	$0	-$94M
Q3 23	$0	$0	-$111M
Q4 23	$0	-$948K	-$154M
Q1 24	$0	$0	-$183M
Q2 24	$0	$0	-$334M
Q3 24	$0	$0	-$178M
Q4 24	$0	$0	-$190M
Q1 25	$0	$0	-$222M
Q2 25	$0	$0	-$212M
Q3 25	$0	-$1M	-$169M
Q4 25	$0	$0	-$143M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$78M	-$78M
Q2 23	-$44M	-$45M
Q3 23	-$95M	-$96M
Q4 23	-$115M	-$115M
Q1 24	-$103M	-$103M
Q2 24	-$168M	-$171M
Q3 24	-$141M	-$142M
Q4 24	-$171M	-$171M
Q1 25	-$165M	-$166M
Q2 25	-$168M	-$168M
Q3 25	-$146M	-$146M
Q4 25	-$131M	-$131M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$735K
Q2 23	$595K
Q3 23	$1M
Q4 23	$470K
Q1 24	$440K
Q2 24	$3M
Q3 24	$611K
Q4 24	$49K
Q1 25	$461K
Q2 25	$233K
Q3 25	$13K
Q4 25	$8K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	-13.4%
Q2 23	—	-52.3%
Q3 23	—	+63.4%
Q4 23	—	-28.0%
Q1 24	—	+135.6%
Q2 24	—	+255.0%
Q3 24	—	+61.2%
Q4 24	—	+23.6%
Q1 25	—	+20.9%
Q2 25	—	-36.6%
Q3 25	—	-4.9%
Q4 25	—	-24.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$4M	—
Q2 23	$5M	—
Q3 23	$4M	—
Q4 23	$0	—
Q1 24	$0	—
Q2 24	$0	—
Q3 24	$12M	—
Q4 24	$13M	—
Q1 25	$53M	—
Q2 25	$21M	—
Q3 25	$22M	—
Q4 25	$17M	—

OpEx Breakdown

Quarter	R&D	G&A
Q1 23	$63M	$14M
Q2 23	$79M	$15M
Q3 23	$96M	$15M
Q4 23	$135M	$19M
Q1 24	$156M	$27M
Q2 24	$315M	$19M
Q3 24	$158M	$21M
Q4 24	$167M	$22M
Q1 25	$188M	$34M
Q2 25	$184M	$27M
Q3 25	$141M	$28M
Q4 25	$122M	$21M

Revenue Segments

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$125M	$263M	$388M
Q2 23	$148M	$188M	$335M
Q3 23	$112M	$129M	$241M
Q4 23	$248M	$133M	$382M
Q1 24	$183M	$101M	$283M
Q2 24	$239M	$198M	$437M
Q3 24	$84M	$294M	$379M
Q4 24	$99M	$387M	$486M
Q1 25	$98M	$224M	$323M
Q2 25	$166M	$239M	$405M
Q3 25	$185M	$75M	$260M
Q4 25	$230M	$89M	$319M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	68M	+12.1%
Q2 23	68M	+0.1%
Q3 23	68M	+0.1%
Q4 23	80M	+17.0%
Q1 24	82M	+2.1%
Q2 24	88M	+7.6%
Q3 24	94M	+7.5%
Q4 24	101M	+7.1%
Q1 25	102M	+0.9%
Q2 25	102M	+0.4%
Q3 25	106M	+3.4%
Q4 25	120M	+13.6%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 19	—	—
FY 20	—	—
FY 21	—	—
FY 22	$0	30K
FY 23	$0	30K
FY 24	$0	15K
FY 25	$0	15K